Patent details

EP2968302 Title: COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS

Basic Information

Publication number:
EP2968302
PCT Application Number:
US2014027556
Type:
European Patent Granted for LU
Legal Status:
Revoked
Application number:
EP147258123
PCT Publication Number:
WO2014152635
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMBINATION OF DIRECT ACTING ANTIVIRAL AGENTS AND RIBAVIRIN FOR TREATING HCV PATIENTS
French Title of Invention:
COMBINAISON D'AGENTS ANTIVIRAUX ET DE RIBAVIRINE POUR TRAITER DES PATIENTS ATTEINTS DU VHC
German Title of Invention:
KOMBINATION AUS DIREKTWIRKENDEN VIRUZIDEN UND RIBAVIRIN ZUR BEHANDLUNG VON HCV-PATIENTEN
SPC Number:

Dates

Filing date:
14/03/2014
Grant date:
06/09/2017
EP Publication Date:
20/01/2016
PCT Publication Date:
25/09/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
06/09/2017
EP B1 Publication Date:
06/09/2017
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
14/03/2034
Renunciation date:
Revocation date:
01/09/2020
Annulment date:

Owner

From:
06/09/2017
 
 

Name:
AbbVie Inc.
Address:
1 North Waukegan Road, North Chicago, IL 60064, United States (US)

Agent

Name:
Office FREYLINGER S.A.
From:
13/12/2017
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
WANG, Tianli
Address:
United States (US)

2

Name:
MENON, Rajeev M.
Address:
United States (US)

3

Name:
MENSING, Sven
Address:
Germany (DE)

4

Name:
BERNSTEIN, Barry M.
Address:
United States (US)

5

Name:
LIU, Wei
Address:
United States (US)

6

Name:
AWNI, Walid M.
Address:
United States (US)

7

Name:
CAMPBELL, Andrew L.
Address:
United States (US)

8

Name:
PODSADECKI, Thomas J.
Address:
United States (US)

9

Name:
LIN, Chih-Wei
Address:
United States (US)

10

Name:
DUTTA, Sandeep
Address:
United States (US)

Priority

Priority Number:
201361783437 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/454; A61K 31/4985; A61K 31/7056; A61P 31/22;

Publication

Bulletin

Bulletin Heading:
VRV
Bulletin edition number:
2020/11
Publication date:
02/10/2020
Description:
Section L: Applications for patents or supplementary protection certificates which have been withdrawn or are deemed to have been withdrawn (art. 32, 35.1, 39.5 of the law) Renunciation to a patent or supplementary protection certificate (Art. 72 of the law) Rejected applications for extensions for pediatric use of supplementary protections certificates

European Patent Bulletin

1

Issue number:
201736
Publication date:
06/09/2017
Description:
Grant (B1)

2

Issue number:
201741
Publication date:
11/10/2017
Description:
Application number/publication number of the divisional application (Art. 76) changed

3

Issue number:
201828
Publication date:
11/07/2018
Description:
Opposition procedure started

4

Issue number:
201907
Publication date:
13/02/2019
Description:
Document reprinted after correction (B8, B9)

5

Issue number:
202041
Publication date:
07/10/2020
Description:
Revocation of the European patent

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
30/12/2019
Last Annual Fee Paid Number:
7
Last Annual Fee Paid Amount:
82 Euro
Payer:
MASTER DATA CENTER INC (ex Clarivate Analytics)
Filing date Document type Number of pages
15/12/2017 Outgoing Correspondence 1
13/12/2017 Power Of Attorney 1